« Previous
Next »
Nanomedicine: Nanotechnology, Biology and Medicine
Volume 3, Issue 2
, Pages 132-137
, June 2007
Development of hyaluronic acid–Fe2O3 hybrid magnetic nanoparticles for targeted delivery of peptides
References
- . Antisense effects in the cell nucleus: modification of splicing. Curr Opin Mol Ther. 2001;3:229–234[1b]. In: Walden P, et al. editor. Targeted AdenoViral vectors for cancer gene therapy. Vol. 57:New York: Plenum Press; 1998;p. 365–374
- . Molecular characterization of a novel intracellular hyaluronan-binding protein. J Biol Chem. 2000;275:29829
- . CD44: from adhesion molecules to signalling regulators. Nat Rev Mol Cell Biol. 2003;4:33
- . Hyaluronan-binding proteins: tying up the giant. J Biol Chem. 2002;277:4585
- . Expression and function of a receptor for hyaluronan-mediated motility on normal and malignant B lymphocytes. Blood. 1993;81:446
- . Internalization of hyaluronan by chondrocytes occurs via receptor-mediated endocytosis. Cell Sci. 1993;106:365
- . Hyaluronic acid as drug delivery for sodium butyrate: improvement of the antiproliferative activity on a breast-cancer cell line. Int J Cancer. 1999;81:411
- . Synthesis and selective cytotoxicity of a hyaluronic acid-antitumor bioconjugate. Bioconjugate Chem. 1999;10:755
- . A hyaluronic acid-taxol antitumor bioconjugate targeted to cancer cells. Biomacromolecules. 2000;1:208
- . Hyaluronic acid therapy. Instr Course Lect. 2000;49:495–502[10b]. Receptor-mediated targeting of magnetic nanoparticles using insulin as a surface ligand to prevent endocytosis. IEEE Trans Nanobiosci. 2003;2:255–261[10c]. Surface-modified superparamagnetic nanoparticles for drug delivery: preparation, characterization, and cytotoxicity studies. IEEE Trans Nanobiosci. 2004;3:66–73[10d]. Surface modification of superparamagnetic magnetite nanoparticles and their intracellular uptake. Biomaterials. 2002;23:1553–1561[10e]. The influence of transferrin stabilised magnetic nanoparticles on human dermal fibroblasts in culture. Int J Pharm. 2004;269:211–225[10f]. Antibody-magnetite nanoparticles: in vitro characterization of a potential tumor-specific contrast agent for magnetic resonance imaging. Bioconjugate Chem. 1993;4:347–352[10g]. Locoregional cancer treatment with magnetic drug targeting. Cancer Res. 2000;60:6641–6648
- . Magnetic drug targeting: biodistribution and dependency on magnetic field. J Magn Mater. 2002;252:363–366[11b]. Applications of nanotechnology to biotechnology commentary. Curr Opin Biotechnol. 2000;11:215–217[11c]. High throughput magnetic resonance imaging for evaluating targeted nanoparticle probes. Bioconjugate Chem. 2002;13:116–121[11d]. Semiconductor nanocrystals as fluorescent biological labels. Science. 1998;281:2013–2016[11e]. Nanostructured materials designed for cell binding and transduction. Biomacromolecules. 2001;2:362–368[11f]. Encapsulation, permeability and cellular uptake characteristics of hollow nanometer-sized conductive polymer capsules. J Phys Chem B. 2001;105:8872[11g]. The permeability of the nuclear envelope in dividing and nondividing cell cultures. Cell Biol. 1990;111:1–8[11h]. Signal-mediated nuclear transport in simian virus 40-transformed cells is regulated by large tumor antigen. Proc Natl Acad Sci U S A. 1992;89:11002–11005
- . FTIR and UV-vis spectroscopy studies of Langmuir-Blodgett films of stearic acid/γ-Fe2O3 nanoparticles. Thin Solid Films. 1998;327:541
No conflict of interest was reported by the authors of this paper.
AK and BS contributed equally to this work.
PII: S1549-9634(07)00043-3
doi: 10.1016/j.nano.2007.03.001
« Previous
Next »
Nanomedicine: Nanotechnology, Biology and Medicine
Volume 3, Issue 2
, Pages 132-137
, June 2007
